Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Benny V Jensen"'
Autor:
Jakob V Schou, Simona Rossi, Benny V Jensen, Dorte L Nielsen, Per Pfeiffer, Estrid Høgdall, Mette Yilmaz, Sabine Tejpar, Mauro Delorenzi, Mogens Kruhøffer, Julia S Johansen
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99886 (2014)
MicroRNAs (miRNAs) have important regulatory functions in cellular processes and have shown promising potential as prognostic markers for disease outcome in patients with cancer. The aim of the present study was to find miRNA expression profiles in w
Externí odkaz:
https://doaj.org/article/c7dcabc9187440ada98fe5aff973a84c
Autor:
Mogens K Boisen, Christian Dehlendorff, Dorte Linnemann, Boye S Nielsen, Jim S Larsen, Kell Osterlind, Svend E Nielsen, Line S Tarpgaard, Camilla Qvortrup, Per Pfeiffer, Niels H Holländer, Nina Keldsen, Torben F Hansen, Brita B Jensen, Estrid V S Høgdall, Benny V Jensen, Julia S Johansen
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109430 (2014)
PURPOSE: We tested the hypothesis that expression of microRNAs (miRNAs) in cancer tissue can predict effectiveness of bevacizumab added to capecitabine and oxaliplatin (CAPEOX) in patients with metastatic colorectal cancer (mCRC). EXPERIMENTAL DESIGN
Externí odkaz:
https://doaj.org/article/6cd8372b3db94d9ebca0c391d81dd6a1
Autor:
Nicolai A Schultz, Ib J Christensen, Jens Werner, Nathalia Giese, Benny V Jensen, Ole Larsen, Jon K Bjerregaard, Per Pfeiffer, Dan Calatayud, Svend E Nielsen, Mette K Yilmaz, Niels H Holländer, Morten Wøjdemann, Stig E Bojesen, Kaspar R Nielsen, Julia S Johansen
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67059 (2013)
PURPOSEWe tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.PATIENTS AND METHODSIn all, 559 patients with pancreatic cancer from prospective biomarker studies from Denmark (n = 448) and
Externí odkaz:
https://doaj.org/article/8a6a74d9b59a499bb6ca083791f000e4
Autor:
Julia S. Johansen, Zoltan Szallasi, Kaspar R. Nielsen, Jane P. Hasselby, Carsten P. Hansen, Dorte L. Nielsen, Stig E. Bojesen, Benny V. Jensen, Astrid Z. Johansen, Inna M. Chen, Emil Maag, Zsófia Sztupinszki, Sidsel C. Lindgaard
Supplementary figure S5 shows an illustration of the proteins in the Olink immuno-oncology panel and the percentage of samples with NPX values missing or values below limit of detection (LOD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763b97021f96a6c4cb63a46a2399cf35
https://doi.org/10.1158/1078-0432.22482080
https://doi.org/10.1158/1078-0432.22482080
Autor:
Julia S. Johansen, Zoltan Szallasi, Kaspar R. Nielsen, Jane P. Hasselby, Carsten P. Hansen, Dorte L. Nielsen, Stig E. Bojesen, Benny V. Jensen, Astrid Z. Johansen, Inna M. Chen, Emil Maag, Zsófia Sztupinszki, Sidsel C. Lindgaard
Supplementary tables S1-S7 show extra details from the manuscript, including the full list of proteins in the Olink Immuno-oncology assay as well as statistical details from the two indices, and a table of recent similar studies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d139ce2cbf6aae2df8a049d682a843e
https://doi.org/10.1158/1078-0432.22482077.v1
https://doi.org/10.1158/1078-0432.22482077.v1
Autor:
Julia S. Johansen, Zoltan Szallasi, Kaspar R. Nielsen, Jane P. Hasselby, Carsten P. Hansen, Dorte L. Nielsen, Stig E. Bojesen, Benny V. Jensen, Astrid Z. Johansen, Inna M. Chen, Emil Maag, Zsófia Sztupinszki, Sidsel C. Lindgaard
eMethods include extra details on the Olink analyses, the statistical analyses, the PubMed search for related articles, as well as REMARK and TRIPOD checklists.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::279e5ffa965bd80c4cc4dae21933252b
https://doi.org/10.1158/1078-0432.22482074
https://doi.org/10.1158/1078-0432.22482074
Autor:
Julia S. Johansen, Zoltan Szallasi, Kaspar R. Nielsen, Jane P. Hasselby, Carsten P. Hansen, Dorte L. Nielsen, Stig E. Bojesen, Benny V. Jensen, Astrid Z. Johansen, Inna M. Chen, Emil Maag, Zsófia Sztupinszki, Sidsel C. Lindgaard
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumors. Most patients are diagnosed at an advanced stage where curative surgery is not an option. The aim of this study was to identify a panel of circulating proteins th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331ce5af1c28d43fcd5f3c9bd99f2fc0
https://doi.org/10.1158/1078-0432.c.6530819
https://doi.org/10.1158/1078-0432.c.6530819
Autor:
Paola Turano, Dorte L. Nielsen, Claudio Luchinat, Mogens Kruhøffer, Julia S. Johansen, Jakob V. Schou, Benny V. Jensen, Stefano Cacciatore, Ivano Bertini
PDF file - 99K, Supplementary Methods and Supplementary Tables S1-S3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f325165d20a27015fd9332a08f96eac
https://doi.org/10.1158/0008-5472.22392174
https://doi.org/10.1158/0008-5472.22392174
Autor:
Rikke Løvendahl Eefsen, Jim S. Larsen, Louise L. Klarskov, Rahim Altaf, Estrid Høgdall, Peter Ingeholm, Jakob Lykke, Dorte L. Nielsen, Per Pfeiffer, Laurids Ø. Poulsen, Camilla Qvortrup, Jakob V. Schou, Morten Mau‐Sørensen, Kell Østerlind, Benny V. Jensen
Publikováno v:
Eefsen, R L, Larsen, J S, Klarskov, L L, Altaf, R, Høgdall, E, Ingeholm, P, Lykke, J, Nielsen, D L, Pfeiffer, P, Poulsen, L Ø, Qvortrup, C, Schou, J V, Mau-Sørensen, M, Østerlind, K & Jensen, B V 2023, ' Therapy with pembrolizumab in treatment-naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer ', International Journal of Cancer, vol. 152, no. 10, pp. 2145-2152 . https://doi.org/10.1002/ijc.34420
Therapy with immune checkpoint inhibitors (ICI) is effective in patients with metastatic mismatch-repair deficient (dMMR) colorectal cancer (CRC); however, data on treatment with neoadjuvant ICI in patients with locally advanced CRC are limited. From
Autor:
Mette Karen Yilmaz, Ursula Falkmer, Kell Østerlind, Louise Skau Rasmussen, Britta Weber, Halla Skuladottir, Laurids Østergaard Poulsen, Martin Bøgsted, Benny V. Jensen, Jim S. Larsen, Per Pfeiffer, Claus Wilki Fristrup, Morten Ladekarl
Publikováno v:
Rasmussen, L S, Fristrup, C W, Jensen, B V, Pfeiffer, P, Weber, B, Yilmaz, M K, Poulsen, L Ø, Ladekarl, M, Østerlind, K, Larsen, J S, Skuladottir, H, Bøgsted, M & Falkmer, U G 2021, ' Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age : A Nationwide Real-World Danish Registry Study ', Pancreas, vol. 50, no. 5, pp. 685-695 . https://doi.org/10.1097/MPA.0000000000001833
Rasmussen, L S, Fristrup, C W, Jensen, B V, Pfeiffer, P, Weber, B, Yilmaz, M K, Poulsen, L, Ladekarl, M, Østerlind, K, Larsen, J S, Skuladottir, H, Bøgsted, M & Falkmer, U G 2021, ' Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age : A Nationwide Real-World Danish Registry Study ', Pancreas, vol. 50, no. 5, pp. 685-695 . https://doi.org/10.1097/MPA.0000000000001833
Rasmussen, L S, Fristrup, C W, Jensen, B V, Pfeiffer, P, Weber, B, Yilmaz, M K, Poulsen, L, Ladekarl, M, Østerlind, K, Larsen, J S, Skuladottir, H, Bøgsted, M & Falkmer, U G 2021, ' Patterns of Palliative Chemotherapy and Survival in Patients with Pancreatic Cancer Focusing on Age : A Nationwide Real-World Danish Registry Study ', Pancreas, vol. 50, no. 5, pp. 685-695 . https://doi.org/10.1097/MPA.0000000000001833
Rasmussen, L S, Fristrup, C W, Jensen, B V, Pfeiffer, P, Weber, B, Yilmaz, M K, Poulsen, L, Ladekarl, M, Østerlind, K, Larsen, J S, Skuladottir, H, Bøgsted, M & Falkmer, U G 2021, ' Patterns of Palliative Chemotherapy and Survival in Patients With Pancreatic Cancer Focusing on Age : A Nationwide Real-World Danish Registry Study ', Pancreas, vol. 50, no. 5, pp. 685-695 . https://doi.org/10.1097/MPA.0000000000001833
Rasmussen, L S, Fristrup, C W, Jensen, B V, Pfeiffer, P, Weber, B, Yilmaz, M K, Poulsen, L, Ladekarl, M, Østerlind, K, Larsen, J S, Skuladottir, H, Bøgsted, M & Falkmer, U G 2021, ' Patterns of Palliative Chemotherapy and Survival in Patients with Pancreatic Cancer Focusing on Age : A Nationwide Real-World Danish Registry Study ', Pancreas, vol. 50, no. 5, pp. 685-695 . https://doi.org/10.1097/MPA.0000000000001833
OBJECTIVES: The aim of this study was to identify patterns of palliative chemotherapy (CTh) and the associated overall survival (OS) in patients with pancreatic cancer, with specific focus on age.METHODS: Between May 1, 2011, and April 30, 2016, 4260